MRC2 Links Collagen Turnover to Integrin/PI3K/AKT‐Driven Fibrogenesis
Advanced Biology · 2026-06 · 10 (6)
DOI: 10.1002/adbi.70133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 08.06.2026. Verfasst von Nuchanart Suntornnont und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Hepatic Stellate Cells, Integrins. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Thailand Science Research and Innovation Fund, Chulalongkorn University, National Research Council of Thailand, Second Century Fund (C2F).
Abstract (Originalsprache)
Liver fibrosis is characterized by excessive collagen accumulation, the principal component of the extracellular matrix (ECM), produced by activated hepatic stellate cells (HSCs). While the catabolic role of mannose receptor C‐type 2 (MRC2) in binding and degradation of collagen is established, its role in regulating pro‐fibrotic signaling remains undefined. We investigated the novel, non‐canonical signaling function of the collagen receptor MRC2 as a regulator of HSC activation. Using doxycycline‐inducible knockdown and overexpression systems in human HSCs, we show that MRC2 deficiency enhances activation phenotypes, including proliferation, migration, contraction, and collagen overproduction. Conversely, MRC2 overexpression suppressed these effects. Transcriptomic analysis of MRC2 knockdown cells revealed a pro‐fibrotic transcriptional shift, with enrichment of pathways related to ECM organization, collagen biosynthesis, and the PI3K/AKT signaling axis. Mechanistically, MRC2 depletion induced transcriptional upregulation of ECM genes and components of the integrin/PI3K/AKT axis, accompanied by increased AKT phosphorylation. Pharmacological inhibition of either PI3K or integrins reversed ECM gene expression and collagen phenotypes induced by MRC2 depletion, establishing these pathways as required mediators. Our findings identify a novel, non‐canonical signaling function of MRC2 as a negative regulator of HSC activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Medical Biochemistry Program, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Laboratory for Immuno Bioengineering Research and Applications, Division of Engineering, New York University Abu Dhabi, Abu Dhabi, UAE.
ORCID-Profile: Jiranuwat Sapudom, Chaiyaboot Ariyachet
Förderung
- Thailand Science Research and Innovation Fund, Chulalongkorn University
- National Research Council of Thailand
- Second Century Fund (C2F)
- Chulalongkorn University
Zitieren
APA
Suntornnont, N., Sapudom, J., & Ariyachet, C. (2026). MRC2 Links Collagen Turnover to Integrin/PI3K/AKT‐Driven Fibrogenesis. Advanced Biology, 10(6). https://doi.org/10.1002/adbi.70133
Vancouver
Suntornnont N, Sapudom J, Ariyachet C. MRC2 Links Collagen Turnover to Integrin/PI3K/AKT‐Driven Fibrogenesis. Advanced Biology. 2026;10(6). doi:10.1002/adbi.70133
BibTeX
@article{Suntornnont2026,
author = {Suntornnont, Nuchanart and Sapudom, Jiranuwat and Ariyachet, Chaiyaboot},
title = {MRC2 Links Collagen Turnover to Integrin/PI3K/AKT‐Driven Fibrogenesis},
journal = {Advanced Biology},
year = {2026},
volume = {10},
number = {6},
doi = {10.1002/adbi.70133}
}
EUVIMED